Ingenia Therapeutics

950260 · KOSDAQ · ₩950260 · 인제니아테라퓨틱스(Reg.S)

₩23,250▲ ₩50 (0.22%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y +29.24%
Market cap
₩1.1T
Enterprise value
₩1.1T
P/E
—
P/B
116,557.6×
Dividend yield
—
ROE
—
Net margin
—

Trailing 12 months from filed financial statements, as of H1 2026.

52-week range−22.4% from the high

₩9,900Today: ₩23,000 – ₩24,250₩29,950

Returns

  • 1W+5.4%
  • 1M−4.7%
  • 3M—
  • 6M—
  • YTD+29.2%
  • 1Y—
Volume today
278,721
0.3× the 20-day average
Traded today
₩6.6B
Listed shares
49,444,607
EPS (12 months)
—
AI researchResearch not started yetResearch starts once this company's financial statements are available.

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

Signals

33Quiet
  • BuzzQuietBuzz 33 of 100 (50 is a normal day for this stock).
  • MomentumFlat-0.9% over the last month; the price is below its 20-day average.
  • News impactSome1 news items and filings in two weeks; 0 rated high impact, 1 medium.

Signals describe activity, not recommendations. Not financial advice.

Leveraged ETF flows

Estimated leveraged-ETF rebalance on Oct 27: buy ₩388M at the close (2.2% of 20-day average trading value)

Sep 28Last 20 trading days (% of average trading value)Oct 27

On its 33 biggest days of the last 60 (moves of 3%+), the estimated pressure averaged 0.9% of trading value and pointed the same way 22 of 33 times.

  • 2× KODEX KOSDAQ150 Leverage ₩316M
  • 2× TIGER KOSDAQ150 Leverage ₩38M
  • -1× KODEX KOSDAQ150 Futures Inverse ₩22M
  • 2× RISE KOSDAQ150 Futures Leverage ₩6.6M
  • 2× KIWOOM KOSDAQ150 Futures Leverage ₩1.7M

Mostly via futures: index funds hedge with KOSPI 200 / KOSDAQ 150 futures, spread here over the index's largest members by market value.

Final after the close. An intraday "if the close were now" estimate needs real-time prices, which we don't have yet.

Estimate based on ETF size and daily moves; actual trades may differ.

ETFs holding this

All ETFs →

Held by 11 funds.

Estimated from the funds' index or underlying stock.

Ingenia Therapeutics stock overview

Ingenia Therapeutics (인제니아테라퓨틱스(Reg.S), KRX: 950260) is listed on KOSDAQ, in the Biotech & Pharma sector. Its shares closed at ₩23,250 on Oct 27, 2026, up 0.22% on the day, giving it a market value of ₩1.1T.

Key facts

Market cap
₩1.1T
Sector
Biotech & Pharma
Latest price change
+0.22%
As of
Oct 27, 2026

Quick answers about Ingenia Therapeutics

What is the market cap of Ingenia Therapeutics?
The market capitalisation of Ingenia Therapeutics was ₩1.1T at the close on Oct 27, 2026.
Who are the largest shareholders of Ingenia Therapeutics?
According to the latest official filings, the largest reported holders are Han Sang-yeol (74.60%, as of Sep 29, 2026); Aureum Asset Management (19.68%, as of Aug 25, 2026); InterVest Open Innovation Private Equity Investment (12.16%, as of Aug 25, 2026).
When is the next earnings report from Ingenia Therapeutics?
Korean companies rarely announce results dates in advance. Based on when Ingenia Therapeutics filed the same report in past years, its next 2q results is expected around Aug 19, 2027.

Company profile

Loading data for this company — check back soon

Korean name
인제니아테라퓨틱스(Reg.S)
CEO
한상열
Founded
Mar 2018
Listed
Aug 2026
Listed shares
49,444,607
Fiscal year ends
Month 12

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Ingenia Therapeutics / 인제니아테라퓨틱스(Reg.S) / 950260 / KRX:950260

Source: KRX statistical information